Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.03B |
| 2 |
McDonald's
MCD
|
+$609M |
| 3 |
UnitedHealth
UNH
|
+$598M |
| 4 |
Strategy Inc
MSTR
|
+$514M |
| 5 |
Qualcomm
QCOM
|
+$469M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.14B |
| 2 |
NVIDIA
NVDA
|
+$1.53B |
| 3 |
Eli Lilly
LLY
|
+$1.08B |
| 4 |
Mastercard
MA
|
+$996M |
| 5 |
Uber
UBER
|
+$932M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.27% |
| 2 | Consumer Discretionary | 12.49% |
| 3 | Financials | 11.57% |
| 4 | Healthcare | 9.6% |
| 5 | Communication Services | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
NCR Voyix
VYX
$1.06B
| $422K | ﹤0.01% |
33,163
-28,242
| -46% | -$286K |
|
1352
iShares MSCI Thailand ETF
THD
$361M
| $421K | ﹤0.01% |
+8,129
| New | +$431K |
|
1353
Camtek
CAMT
$6.9B
| $419K | ﹤0.01% |
4,791
| – | – |
|
1354
Baidu
BIDU
$35.8B
| $419K | ﹤0.01% |
4,843
-281
| -5% | -$24.2K |
|
1355
Banner Corp
BANR
$2.39B
| $418K | ﹤0.01% |
6,217
-8,975
| -59% | -$555K |
|
1356
Tidewater
TDW
$3.91B
| $417K | ﹤0.01% |
+8,735
| New | +$354K |
|
1357
WaFd
WAFD
$2.72B
| $416K | ﹤0.01% |
+13,467
| New | +$381K |
|
1358
Simmons First National
SFNC
$3.35B
| $416K | ﹤0.01% |
20,742
-29,767
| -59% | -$561K |
|
1359
REX American Resources
REX
$1.46B
| $414K | ﹤0.01% |
16,112
-1,644
| -9% | -$34.7K |
|
1360
Seacoast Banking Corp of Florida
SBCF
$3.26B
| $412K | ﹤0.01% |
14,024
-20,113
| -59% | -$497K |
|
1361
Corcept Therapeutics
CORT
$10.2B
| $411K | ﹤0.01% |
5,766
+1,827
| +46% | +$132K |
|
1362
Hertz
HTZ
$572M
| $406K | ﹤0.01% |
56,654
+23,211
| +69% | +$145K |
|
1363
First Financial Bancorp
FFBC
$3.55B
| $404K | ﹤0.01% |
15,774
-22,672
| -59% | -$538K |
|
1364
Ooma
OOMA
$550M
| $402K | ﹤0.01% |
30,923
| – | – |
|
|
CPRX
1365
DELISTED
Catalyst Pharmaceutical
CPRX
| $401K | ﹤0.01% |
18,687
-26,444
| -59% | -$624K |
|
1366
Sylvamo
SLVM
$1.52B
| $399K | ﹤0.01% |
7,199
-8,440
| -54% | -$475K |
|
1367
Kulicke & Soffa
KLIC
$5.3B
| $397K | ﹤0.01% |
11,015
-12,997
| -54% | -$423K |
|
1368
SLM Corp
SLM
$4.57B
| $396K | ﹤0.01% |
11,795
+127
| +1% | +$3.88K |
|
1369
Alamo Group
ALG
$2.01B
| $392K | ﹤0.01% |
1,740
-2,471
| -59% | -$472K |
|
1370
Axcelis
ACLS
$4.12B
| $391K | ﹤0.01% |
5,353
-545,694
| -99% | -$31.1M |
|
1371
Amneal Pharmaceuticals
AMRX
$5.72B
| $388K | ﹤0.01% |
46,392
+14,628
| +46% | +$110K |
|
1372
Televisa
TV
$1.45B
| $387K | ﹤0.01% |
167,721
| – | – |
|
1373
ePlus
PLUS
$2.33B
| $386K | ﹤0.01% |
5,380
+19
| +0.4% | +$1.25K |
|
1374
AMN Healthcare
AMN
$1.28B
| $386K | ﹤0.01% |
17,521
+2,067
| +13% | +$43K |
|
1375
Viavi Solutions
VIAV
$9.75B
| $382K | ﹤0.01% |
36,827
-51,534
| -58% | -$498K |
|
Similar funds
Amundi's Q2 2025 Portfolio in Review
As of Q2 2025, Amundi held 2,245 positions worth $290B, up 5.5% from $275B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Amundi withdrew a net $25.8B in Q2 2025, closing 579 positions and reducing 831 holdings. Its most notable exit was Novo Nordisk, an estimated $332M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Amundi opened a new position in Victory Capital Holdings worth $213M.
- Amundi's largest Q2 2025 buy was Victory Capital Holdings: 3,293,471 shares worth $213M.
- Amundi added most to Tesla in Q2 2025, an estimated $1.03B increase.
- Amundi's biggest Q2 2025 reduction was Microsoft, cutting an estimated $3.14B.
- Amundi fully exited Novo Nordisk in Q2 2025, selling an estimated $332M.
- Amundi's ten largest holdings make up 31% of its $290B portfolio in Q2 2025.
- Amundi opened 66 new positions and closed 579 in Q2 2025.
- Amundi's portfolio value rose 5.5% quarter-over-quarter to $290B.
Based on Amundi's 13F filing for Q2 2025, filed 13 Aug 2025.